首页> 外文期刊>Medical dosimetry: official journal of the American Association of Medical Dosimetrists >Determination of critical dosimetric parameters for breast radiation using forward-planned segmented fields for intensity modulation.
【24h】

Determination of critical dosimetric parameters for breast radiation using forward-planned segmented fields for intensity modulation.

机译:使用前瞻性分割场进行强度调制,确定乳腺辐射的关键剂量参数。

获取原文
获取原文并翻译 | 示例
       

摘要

The purpose of this study was to determine factors associated with acute skin toxicity from breast radiation for optimizing forward-planned intensity modulation. Treatment plans in 100 patients who received breast radiation using three-dimensional treatment planning were analyzed. Fifty-two patients were treated with tangent fields using wedges (nonsegmented), and 48 patients were treated with forward-planned fields segmented by a multileaf collimator to modulate intensity. Clinical and dosimetric variables were recorded. Acute skin toxicity was prospectively documented using a standard scale. Body weight, breast target volume, maximum body dose (encompassing 10 mL), and volume of body receiving >50 Gy and 55 Gy (V50Gy, and V55Gy) were associated with acute toxicity. Patients treated with segmented plans had significantly larger breast targets and were treated to lower prescription isodoses, confounding comparison with nonsegmented plans. Consequently, datasets from patients treated with segmented plans were used to design new nonsegmented plans for paired comparison. Segmented plans were superior with respect to dosimetric endpoints predictive of toxicity in this paired comparison. Limitations of 55 Gy for maximum body dose and 1100 mL for V50Gy appeared to be appropriate values to guide forward treatment planning of segmented fields.
机译:这项研究的目的是确定与乳房放射线引起的急性皮肤毒性有关的因素,以优化前瞻性强度调制。使用三维治疗计划,对100例接受了放射治疗的患者的治疗计划进行了分析。 52例患者使用楔形物(非分段)切线场治疗,48例患者使用多叶准直仪分割以调节强度的前瞻性视野。记录临床和剂量学变量。前瞻性使用标准量表记录了急性皮肤毒性。体重,乳房目标体积,最大体重(超过10 mL)和接受> 50 Gy和55 Gy的身体体积(V50Gy和V55Gy)与急性毒性相关。采用分段计划治疗的患者的乳房靶点明显更大,并且接受了更低的处方同工酶治疗,这与未分段计划的比较令人困惑。因此,来自使用分段计划治疗的患者的数据集被用于设计新的非分段计划以进行配对比较。在该配对比较中,分段计划在预测毒性的剂量学终点方面要好。最大身体剂量限制为55 Gy,V50Gy限制为1100 mL,这是指导分段治疗的前瞻性治疗计划的适当值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号